A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Name: A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.
Published: 2023
License: Public Domain

AstraZeneca · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

idiopathic-pulmonary-fibrosis pharmacokinetics

healthy subjects, drug-drug interaction, idiopathic pulmonary fibrosis, interstitial lung diseases with progressive fibrosis, porcupine inhibitor, pharmacokinetics, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Related documents